# Replication of the RELY Anticoagulant Trial in Healthcare Claims Data

> **NCT04593043** · — · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 78140 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** Warfarin
- **DRUG:** Dabigatran

## Key facts

- **NCT ID:** NCT04593043
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-01
- **Primary completion:** 2021-02-18
- **Final completion:** 2021-02-18
- **Target enrollment:** 78140 (ACTUAL)
- **Last updated:** 2023-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04593043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04593043, "Replication of the RELY Anticoagulant Trial in Healthcare Claims Data". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT04593043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*